Skip to main content

Table 4 Disease severity, organ dysfunction and mortality for JAAM DIC score on inclusion day (day 1)

From: A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis

 

JAAM DIC score

 

0 ( n = 19)

1 ( n = 89)

2 ( n = 143)

3 ( n = 81)

4 ( n = 59)

5 ( n = 105)

6 ( n = 59)

7 ( n = 19)

8 ( n = 50)

APACHE II score

22.3 ± 7.8

20.2 ± 7.6

21.8 ± 7.5

23.7 ± 8.6

23.4 ± 7.9

26.1 ± 9.1bc

25.1 ± 7.0b

25.0 ± 9.1

26.0 ± 9.2b

SIRS score

1.7 ± 0.5

2.8 ± 1.0

3.2 ± 0.7

3.4 ± 0.7

2.9 ± 1.0ad

3.3 ± 0.7ab

3.5 ± 0.5ab

2.7 ± 1.0a

3.6 ± 0.5abc

SOFA score

6.5 ± 3.7

5.7 ± 3.3

6.7 ± 2.9

8.0 ± 3.5

9.4 ± 3.4bc

10.0 ± 4.2abcd

11.4 ± 3.2abcd

11.5 ± 3.4abcd

11.9 ± 3.6abcd

SOFA peak score during study period

6.8 ± 3.8

6.1 ± 3.4

7.4 ± 3.3

8.7 ± 3.6

10.0 ± 3.5bc

11.0 ± 4.2abcd

11.9 ± 3.3abcd

12.3 ± 3.1abcd

13.0 ± 3.8abcd

MODS (%)

42.1

32.6

37.1

54.3

55.9bc

61.9bc

72.9abcd

63.2b

76.0abcd

28-day mortality (%)

5.3

10.1

18.9

19.8

27.1b

37.1abcd

27.1ab

31.6ab

28.0ab

Hospital mortality (%)

10.5

14.6

25.2

25.9

30.5ab

43.8abcd

35.6ab

42.1ab

38.0ab

  1. APACHE, Acute Physiology and Chronic Health Evaluation; DIC, disseminated intravascular coagulation; JAAM, Japanese Association for Acute Medicine; MODS, multiple organ dysfunction syndrome; SIRS, Systemic Inflammatory Response Syndrome; SOFA, Sequential Organ Failure Assessment. Analyses of variance of APACHE II, SIRS and SOFA are as follows: P <0.001, aP <0.05 versus 0, bP <0.05 versus 1, cP <0.05 versus 2, dP <0.05 versus 3.